Join
Live feed
·
PRReleasevia Quantisnow
Vistagen Therapeutics Inc. logo

Vistagen Announces Completion of Last Patient Visit in PALISADE-4 Phase 3 Public Speaking Challenge Study of Fasedienol for Acute Treatment of Social Anxiety Disorder

ByQuantisnow·Wall Street's wire, on your screen.
VTGN· Vistagen Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VTGN (Vistagen Therapeutics Inc.) and more on Quantisnow.